These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 17029248

  • 1. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 3. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.
    Cancer; 2004 Feb 15; 100(4):834-42. PubMed ID: 14770442
    [Abstract] [Full Text] [Related]

  • 4. Results of a prospective study for the treatment of unilateral retinoblastoma.
    Chantada GL, Fandiño AC, Guitter MR, Raslawski EC, Dominguez JL, Manzitti J, de Dávila MT, Zubizarreta P, Scopinaro M.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):60-6. PubMed ID: 20486172
    [Abstract] [Full Text] [Related]

  • 5. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.
    Chantada GL, Casco F, Fandiño AC, Galli S, Manzitti J, Scopinaro M, Schvartzman E, de Dávila MT.
    Ophthalmology; 2007 Nov 15; 114(11):2083-9. PubMed ID: 17459482
    [Abstract] [Full Text] [Related]

  • 6. Treatment of overt extraocular retinoblastoma.
    Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E.
    Med Pediatr Oncol; 2003 Mar 15; 40(3):158-61. PubMed ID: 12518344
    [Abstract] [Full Text] [Related]

  • 7. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL.
    J Clin Oncol; 2011 Mar 01; 29(7):845-51. PubMed ID: 21282531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan 01; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 14. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A.
    Arch Ophthalmol; 2011 Nov 01; 129(11):1422-7. PubMed ID: 22084213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA.
    Ophthalmology; 2006 Nov 01; 113(11):2087-92. PubMed ID: 16949158
    [Abstract] [Full Text] [Related]

  • 20. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug 01; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.